ArticleCell death & disease2022

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.

Santiago Madera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.